FDA concerns about unapproved GLP-1 receptor agonists

Reactions Weekly 2026

View at publisher
DOI: 10.1007/s40278-026-92496-3
Cited by: 1
References: 1

Fields of Study & Subjects

Diabetes Treatment and Management Adenosine and Purinergic Signaling Receptor Mechanisms and Signaling

Publication details

Journal / source
Reactions Weekly
Publisher
Springer Science and Business Media LLC
Volume
2097
Issue
1
Pages
2–2
Publication date
12 February 2026
Language
EN